Comprehensive genomic profiling (CGP) is increasingly adopted to characterize the molecular architecture of tumors, providing actionable insights into cancer biology and supporting biomarker discovery. As sequencing costs fall and bioinformatics tools become more accessible, the adoption continues to grow.

In this webinar, we showcase the new QIAseq xHYB CGP Panels, which deliver a robust, multimodal solution for comprehensive cancer profiling. These expertly curated panels target 724 DNA genes (SNVs, indels, CNVs, TMB, MSI) and 274 RNA genes (fusions, splicing, exon-skipping), offering broad coverage of clinically relevant variants. Optimized probe design ensures reliable data from both FFPE and liquid biopsy samples, even in challenging regions.

QIAseq xHYB CGP Panels can be combined with the QIAseq Multimodal DNA/RNA Library Kit to obtain sequencing-ready libraries from a single sample in 1.5 days. This approach maximizes biomarker insights for deeper tumor biology exploration and precision oncology strategies.